PureTech Health Affiliate C Diff Infection Phase 1 Study Successful
LONDON (Alliance News) - PureTech Health PLC said Thursday affiliate Vedanta Biosciences preliminary results from its clostridium difficile infection study showed the drug is "safe and phase Read More